Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Usana Health Sciences Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 198 | 1 | 188 | −9 |
| Shares | 11.5M | 4.22K | 11.1M | −431.8K (−3.7%) |
| Value | $1.12B | $412.0K | $1.14B | +$11.7M (+1.0%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Usana Health Sciences Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgewater Associates, LP | 36,530 | $3.74M | 0.02% |
| Amundi | 11,534 | $1.18M | 0.00% |
| HRT Financial LP | 11,397 | $1.17M | 0.01% |
| Blueshift Asset Management, LLC | 8,082 | $828.0K | 0.05% |
| Raymond James Financial Services Advisors, Inc. | 7,821 | $801.0K | 0.00% |
| Amalgamated Bank | 6,440 | $660.0K | 0.01% |
| Voloridge Investment Management, LLC | 5,545 | $568.0K | 0.00% |
| Handelsbanken Fonder AB | 3,800 | $389.0K | 0.00% |
| Occudo Quantitative Strategies LP | 3,685 | $377.0K | 0.06% |
| ExodusPoint Capital Management, LP | 3,306 | $339.0K | 0.01% |
| AlphaCrest Capital Management LLC | 2,823 | $289.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 2,700 | $277.0K | 0.00% |
| Virtu Financial LLC | 2,550 | $261.0K | 0.03% |
| Crew Capital Management, Ltd. | 2,000 | $205.0K | 0.19% |
| Intersect Capital LLC | 1,957 | $200.0K | 0.04% |
| Penserra Capital Management LLC | 158 | $16.0K | 0.00% |
Sold out (25)
Institutions that held Usana Health Sciences Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Caas Capital Management LP | 141,009 | $13.8M |
| California Public Employees Retirement System | 23,600 | $2.30M |
| Stifel Financial Corp | 20,800 | $2.03M |
| Mackay Shields LLC | 20,700 | $2.02M |
| HighTower Advisors, LLC | 19,530 | $1.91M |
| Pacer Advisors, Inc. | 15,899 | $1.55M |
| M&G Investment Management Ltd | 13,754 | $1.35M |
| Aviva PLC | 12,677 | $1.24M |
| CIBC World Markets Inc. | 11,939 | $1.17M |
| Mitsubishi UFJ Trust & Banking Corp | 8,284 | $809.0K |
| Susquehanna International Group, LLP | 6,867 | $670.0K |
| Jefferies Group LLC | 6,700 | $653.9K |
| Qube Research & Technologies Ltd | 4,973 | $485.0K |
| Jump Financial, LLC | 4,683 | $457.0K |
| Janney Montgomery Scott LLC | 4,220 | $412.0K |
| Squarepoint Ops LLC | 3,758 | $367.0K |
| Guggenheim Capital LLC | 3,629 | $354.0K |
| AMP Capital Investors Ltd | 3,026 | $295.0K |
| LPL Financial LLC | 2,699 | $263.0K |
| Paloma Partners Management Co | 2,663 | $260.0K |
| Centiva Capital, LP | 2,228 | $217.0K |
| Group One Trading, L.P. | 106 | $10.0K |
| Carroll Financial Associates, Inc. | 86 | $8.00K |
| Valeo Financial Advisors, LLC | 34 | $3.00K |
| Sowell Financial Services LLC | 21 | $2.00K |
Not filed for Q2 2021 yet (1)
Institutions that held Usana Health Sciences Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 4,223 | $412.0K |